Minnie Pearl

Be The Match Announces Winners of 2023 NMDP/Be The Match Awards

Retrieved on: 
Monday, November 27, 2023
NMDP, Stanford University, Caregiver, National Marrow Donor Program, Research, Leukemia, HLA, Minnie Pearl, Congress, Cancer, GVHD, Stanford University Medical Center, Patient, Diagnosis, Organization, SHC, Bone marrow, Immune disorder, AML, Dentistry

MINNEAPOLIS, Nov. 27, 2023 (GLOBE NEWSWIRE) -- National Marrow Donor Program (NMDP)/Be The Match®, today announced the recipients of its annual NMDP/Be The Match Awards at The ONE Forum 2023.

Key Points: 
  • MINNEAPOLIS, Nov. 27, 2023 (GLOBE NEWSWIRE) -- National Marrow Donor Program (NMDP)/Be The Match®, today announced the recipients of its annual NMDP/Be The Match Awards at The ONE Forum 2023.
  • The awards honor individuals, groups, NMDP/Be The Match Network members or organizations working to increase awareness or access to potentially life-saving cell therapy.
  • The 2023 NMDP/Be The Match Award recipients are:
    Dr. Mukherjee’s idea for a new approach to cancer treatment led to groundbreaking research that has the potential to transform outcomes for patients with AML and other blood cancers.
  • “We are honored to celebrate and acknowledge the contributions of this year’s NMDP/Be The Match Award winners,” said Amy Ronneberg, Chief Executive Officer for NMDP/Be The Match.

Elligo Health Research® Names Dawn Sauro as New Chief Operating Officer

Retrieved on: 
Thursday, January 5, 2023
Health, Practice Management, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Research strategies of election campaign communication research, Drug development, Research, Health minister, Multimedia, Human Development Innovation Fund, Minnie Pearl, Cros, Patient, Hematology-Oncology and Stem Cell Transplantation Research Center, Hematology, Senior, Pharmaceutical industry

Elligo Health Research , the largest healthcare-enabling research organization, today announced that Dawn Sauro has been named as Elligo’s Chief Operating Officer (COO) to help further the company’s growth, efficiency, and mission of optimizing the intersection of healthcare and research through direct access to patients, new technology, and custom research practice management solutions.

Key Points: 
  • Elligo Health Research , the largest healthcare-enabling research organization, today announced that Dawn Sauro has been named as Elligo’s Chief Operating Officer (COO) to help further the company’s growth, efficiency, and mission of optimizing the intersection of healthcare and research through direct access to patients, new technology, and custom research practice management solutions.
  • View the full release here: https://www.businesswire.com/news/home/20230105005290/en/
    Dawn Sauro is Elligo Health Research’s new Chief Operating Officer.
  • Prior to joining Elligo, Sauro was Chief Development Officer at Clinipace Clinical Research (now Caidya) where she grew the organization to be a trusted partner for sponsors across a variety of therapeutic areas.
  • Prior roles also included President, Development Innovations at Sarah Cannon and Senior Vice President and General Manager, Hematology/Oncology at inVentiv Health (now Syneos).

Brook Blackmore Joins Azra AI as Vice President of Clinical Operations

Retrieved on: 
Tuesday, May 17, 2022
Education, Strategic planning, AI, Tennessee State University, Patient, Azra, Minnie Pearl, Eye, Nursing, City, University, Hospital, Inspira Health Network, Technology, Belmont University, HCA Healthcare, Cancer, Medical Education Number, CEO, Medical device, Medicine, Western Governors University

In her new role, Blackmore will oversee strategic planning for clinical use of the company's proprietary AI software.

Key Points: 
  • In her new role, Blackmore will oversee strategic planning for clinical use of the company's proprietary AI software.
  • Blackmore will serve as the Vice President of Clinical Operations at Azra AI , overseeing strategic planning for clinical use of the company's proprietary AI software.
  • Her move to Azra AI comes after serving as Vice President of Clinical Operations at Thyme Care, a Nashville-based organization that provides support and resources to people with cancer.
  • Chris Cashwell, CEO of Azra AI, said that he and his team are thrilled to have Blackmore join their ranks.

Andy Corts Appointed OneOncology Chief Technology Officer

Retrieved on: 
Tuesday, December 14, 2021
LinkedIn, Cortes, CIO, Government, Clinical trial, Verily, Cancer Institute, HCA, Cancer, Time, Alphabet, Clinical trial management system, Data science, CEO, Patient, Minnie Pearl, Multimedia, MD, Technology, Pharmaceutical industry, Medical imaging, Medicine, Research

NASHVILLE, Tenn., Dec. 14, 2021 /PRNewswire/ --OneOncology, the national platform for independent community oncology practices,announced today that health technology industry veteran, Andy Corts, has joined the company as its Chief Technology Officer.

Key Points: 
  • NASHVILLE, Tenn., Dec. 14, 2021 /PRNewswire/ --OneOncology, the national platform for independent community oncology practices,announced today that health technology industry veteran, Andy Corts, has joined the company as its Chief Technology Officer.
  • Andy Corts brings unparalleled experience at the intersection of technology, clinical trials and value-based care.
  • Prior to SignalPath, Corts spent ten years as Chief Information Officer (CIO) at Sarah Cannon, the Cancer Institute of HCA.
  • "Andy brings unparalleled experience at the intersection of technology, clinical trials and value-based care," said Jeff Patton, MD, OneOncology's CEO.

American Oncology Network & Sarah Cannon Research Institute Expand Cancer Research Collaboration with Addition of Genesis Cancer and Blood Institute

Retrieved on: 
Wednesday, September 22, 2021
Clinical trial, Cancer, AON, Minnie Pearl, Partnership, Research, III, Sarah Cannon Research Institute, Patient, Pathology, Physician, MD, LLC, HCA, Â, Drug development, CRO, Practitioner, Genesis, Clinical research, Quality of life, Travel, GLOBE, Pharmaceutical industry, Medicine

Fort Myers, Fla. & Nashville, Tenn., Sept. 22, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner practice Genesis Cancer and Blood Institute (Genesis), as a strategic research site.

Key Points: 
  • Fort Myers, Fla. & Nashville, Tenn., Sept. 22, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner practice Genesis Cancer and Blood Institute (Genesis), as a strategic research site.
  • This new partnership with Sarah Cannon Research Institute will provide patients access to an expanded menu of clinical trials and advanced therapies.
  • The physicians at Genesis Cancer and Blood Institute are committed to delivering advanced treatment options for the best possible outcomes for their patients, said AON CEO Todd Schonherz.
  • About Sarah Cannon Research Institute: ( SarahCannon.com )
    Sarah Cannon Research Institute is the research arm of HCA Healthcares Cancer Institute, Sarah Cannon.

American Oncology Network & Sarah Cannon Research Institute Expand Cancer Research Collaboration with Addition of Zangmeister Cancer Center

Retrieved on: 
Monday, April 19, 2021
Musicians, HCA Healthcare, Sarah Cannon Research Institute, Minnie Pearl, National Association of Orthopaedic Nurses, Medical specialties, Tennessee

b'Fort Myers, Fla. & Nashville, Tenn., April 19, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner practice Zangmeister Cancer Center (Zangmeister), as a strategic research site.

Key Points: 
  • b'Fort Myers, Fla. & Nashville, Tenn., April 19, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner practice Zangmeister Cancer Center (Zangmeister), as a strategic research site.
  • Zangmeister physicians deliver the most advanced cancer treatments customized for each patient so they can achieve the best possible outcome.
  • \xe2\x80\x9cTheir partnership with Sarah Cannon Research Institute enables access to a broader range of innovative research studies within the community, matching patients with potentially life-saving treatments.\xe2\x80\x9d\nAON is currently comprised of an expanding network of partner practices across 16 states.
  • Additionally, Sarah Cannon offers management, regulatory, and other research support services for drug development and industry sponsors as well as strategic investigator sites through its contract research organization (CRO), Sarah Cannon Development Innovations.\n'